Skip to content

Effect of percutaneous acupoint electrical stimulation on postoperative anti-inflammatory effects in patients with complete laparoscopic distal gastric cancer: a multicenter prospective randomized controlled trial

Effect of percutaneous acupoint electrical stimulation on postoperative anti-inflammatory effects in patients with complete laparoscopic distal gastric cancer: a multicenter prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083948
Enrollment
Unknown
Registered
2024-05-08
Start date
2024-05-10
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Experimental Group (A):Percutaneous acupoint electrical stimulation (ST36, ST37, ST39, ST41) was used on the 1st to 5th day after surgery.
Control group (A):A blank control was used on the 1st to 5th day after surgery

Sponsors

WeiFang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. All patients provided written informed consent before enrollment. 2. Gastric cancer was confirmed by gastroscopic pathology in all patients. 3. The patient's age is greater than or equal to 18 years old and less than or equal to 80 years old. 4. All patients underwent complete laparoscopic radical gastrectomy without conversion to laparotomy.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Have a history of upper abdominal surgery (except cholecystectomy), or need to be operated at the same time as other operations. 2. The patient needs to be transferred to open surgical intensive care for more than 24 hours after surgery. 3. Have a history of syncope or epilepsy. 4. Epidural anesthesia during surgery. 5. Take medications that affect bowel function within a month. 6. Emergency surgery is required for bleeding, obstruction, or perforation. 7. Participating in other clinical studies or receiving acupuncture treatment within the past 3 months. 8. Mentally incapacitated or suffering from serious emotional or mental illness. 9. Pacemaker implantation status. 10. Current or past diabetes. 11.. Systemic infection or infectious disease

Design outcomes

Primary

MeasureTime frame
IL-6;

Secondary

MeasureTime frame
IL-10;IL-2;Number of lymphocyte subsets (CD3+, CD4+, CD8+);Postoperative gastrointestinal function recovery time (exhaust time);

Countries

China

Contacts

Public ContactQu Jianjun

WeiFang People's Hospital

15153608083@163.com+86 151 5360 8083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026